Further, rapid decreasing NT-proBNP levels indicative of cardiac response in AL amyloidosis are attributed to reduction of direct cardiotoxicity by reduced levels of circulating free light chains under treatment. This evidence concerns the gene NPPB and AL amyloidosis.